UnknownPHASE1, PHASE2NCT04601584

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
AO GENERIUM
Principal Investigator
Oksana A. Markova, MD
AO GENERIUM
Intervention
Cohort 1, GNR-084(biological)
Enrollment
36 enrolled
Eligibility
18-45 years · All sexes
Timeline
20202025

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04601584 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials